🧫
Dexamethasone treatment study in α-synuclein mice
active
experiment
Created: 2026-04-10T22:34:48
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-cd85e950-e169-432f-a651-510fdde03f01
🧫 Experiment Protocol
ValidationParkinson's diseaseSNCAThy1.2-α-synuclein transgenic miceproposed
A therapeutic intervention study was performed using Thy1.2-α-synuclein mice treated with dexamethasone starting at 5 months of age for 1 month duration. The study assessed the effects of anti-inflammatory treatment on microglial response in the brain and motor function using wheel-running activity tests. Results showed that dexamethasone treatment significantly decreased the microglial response in the brain and promoted functional recovery in motor performance. This experiment demonstrated that inhibiting inflammation can provide beneficial effects on motor phenotypes in an animal model of α-synucleinopathy, supporting the therapeutic potential of anti-inflammatory approaches in Parkinson's disease.
PRIMARY OUTCOME
microglial response and motor function (wheel-running activity)
EXPECTED OUTCOMES
Reduced microglial response and improved motor function
SUCCESS CRITERIA
Significant decrease in microglial response and functional recovery in motor tests
PROTOCOL
Dexamethasone treatment for 1 month starting at 5 months of age, followed by assessment of brain microglia and wheel-running activity
Source: PMID 25522431 ↗
🧫 Experiment Extras
PATHWAY
neuroinflammation, microglial activation
MARKET PRICE
$0.50
STATUS
proposed
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.